Intrinsic Value

The intrinsic value of Carasent AB (publ) (CARA) under the Base Case is 16.52 SEK per share. Compared with the current market price of 25.85 SEK, the stock appears Overvalued by 36% .

The intrinsic value is calculated using the DCF method. The model assumes net margin rises from 10% last year to 15% by 2031, above last year's 10%. Revenue grows about 16% a year over the next five years.

Do our valuations actually work? See backtest results .

CARA Intrinsic Value
kr16.52
Overvaluation 36%
Intrinsic Value
Price kr25.85
C

CARA is valued in line with its history. A premium of this size has been typical over the past 4 years.

Monitor CARA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value kr13.22
Get notified when the price drops into your buy zone
Current Price kr25.85
Intrinsic Value kr16.52
Margin of Safety 20% kr13.22
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to CARA

Fundamental Analysis

What Carasent AB Does

Health Care

Carasent AB is a software company focused on healthcare administration. It sells digital tools that help clinics, doctors, and other care providers manage patient records, appointments, billing, and communication with patients. Its main product set is built around electronic health record and practice management software used in outpatient healthcare.

Headquarters
Sweden SE
Employees
196
IPO date
Dec 9, 2024
Read the full company overview
View Company Overview
Financials

Revenue & Expenses Breakdown
Carasent AB (publ)

Efficiency

Earnings Waterfall
Carasent AB (publ)

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one CARA stock?

The intrinsic value for Carasent AB (publ) (CARA) under the Base Case is 16.52 SEK.

Is CARA stock undervalued or overvalued?

Compared with the current market price of 25.85 SEK, the stock appears Overvalued by 36% .

Back to Top